Updated findings from a phase 3 study show significantly better 8-year progression-free survival with external beam radiation therapy added to androgen deprivation therapy (ADT) vs ADT alone.
Prostate mpMRI findings before and after neoadjuvant therapy prior to robotic prostatectomy could be useful in assessing whether high-risk patients are suitable surgical candidates.
In a study of patients with type 2 diabetes and chronic kidney disease, canagliflozin, an SGLT2 inhibitor, decreased the risk of end-stage renal disease by 32% compared with placebo.
New study finds that Vietnam War exposure to the defoliant Agent Orange is associated with a reduced death risk among men receiving androgen deprivation therapy for advanced prostate cancer.
Radiation therapy administered after surgery for advanced upper tract urothelial carcinoma improves cancer-specific and distant metastasis-free survival, a study found.
Data support first-line treatment with combined regimens that include an immunotherapeutic agent
Hyperkalemia vs normokalemia at admission to a cardiac intensive care unit was associated with 44% increased odds of in-hospital mortality, independent of illness severity and renal function.
Biparametric MRI detects prostate tumors with an accuracy similar to that of multiparametric MRI without the cost and risks associated with intravenous gadolinium contrast, a new meta-analysis suggests.
During a session at the 2019 Genitourinary Cancers Symposium (GUCS) held recently in San Francisco, researchers presented findings from phase 3 studies showing that immunotherapy-based combination regimens are superior to sunitinib alone at improving progression-free survival among patients with previously untreated advanced kidney cancer. One study demonstrated improved overall survival. The study presenters concluded that…
In a study, 94% of men with inflammatory bowel disease had erectile dysfunction.
